- Home
- SABS vs HYFM Comparison
SABS vs HYFM Comparison
Compare SABS & HYFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- HYFM
- Stock Information
- Founded
- SABS 2014
- HYFM 1977
- Country
- SABS United States
- HYFM United States
- Employees
- SABS N/A
- HYFM N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- HYFM Industrial Machinery/Components
- Sector
- SABS Health Care
- HYFM Industrials
- Exchange
- SABS Nasdaq
- HYFM Nasdaq
- Market Cap
- SABS 15.8M
- HYFM 15.0M
- IPO Year
- SABS N/A
- HYFM 2020
- Fundamental
- Price
- SABS $2.34
- HYFM N/A
- Analyst Decision
- SABS Strong Buy
- HYFM
- Analyst Count
- SABS 4
- HYFM 0
- Target Price
- SABS $9.50
- HYFM N/A
- AVG Volume (30 Days)
- SABS 481.4K
- HYFM 25.0K
- Earning Date
- SABS 11-05-2025
- HYFM 11-06-2025
- Dividend Yield
- SABS N/A
- HYFM N/A
- EPS Growth
- SABS N/A
- HYFM N/A
- EPS
- SABS N/A
- HYFM N/A
- Revenue
- SABS $114,698.00
- HYFM $161,102,000.00
- Revenue This Year
- SABS N/A
- HYFM N/A
- Revenue Next Year
- SABS N/A
- HYFM $37.86
- P/E Ratio
- SABS N/A
- HYFM N/A
- Revenue Growth
- SABS N/A
- HYFM N/A
- 52 Week Low
- SABS $1.00
- HYFM $1.50
- 52 Week High
- SABS $6.60
- HYFM $8.55
- Technical
- Relative Strength Index (RSI)
- SABS 55.11
- HYFM 39.39
- Support Level
- SABS $1.85
- HYFM $2.96
- Resistance Level
- SABS $2.49
- HYFM $3.17
- Average True Range (ATR)
- SABS 0.21
- HYFM 0.25
- MACD
- SABS 0.01
- HYFM 0.03
- Stochastic Oscillator
- SABS 47.00
- HYFM 25.56
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About HYFM Hydrofarm Holdings Group Inc.
Hydrofarm Holdings Group Inc is a distributor and manufacturer of agriculture equipment and supplies. Some of its products includes lighting solutions, growing media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies sold under proprietary, exclusive/preferred brands, or non-exclusive/distributed brands. The business is organized into two operating segments, the U.S. and Canada.